About the Authors

Maroua Ferhat

Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Julia Mayer

Roles Methodology, Writing – review & editing

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Lyndon H. Costa

Roles Methodology, Writing – review & editing

Affiliation Department of Immunology and Inflammation, Centre for Inflammatory Disease, Hammersmith Hospital, Imperial College London (ICL), London, United Kingdom

Maria Prendecki

Roles Methodology, Writing – review & editing

Affiliation Department of Immunology and Inflammation, Centre for Inflammatory Disease, Hammersmith Hospital, Imperial College London (ICL), London, United Kingdom

Alejandro A. Puchol Tarazona

Roles Methodology, Writing – review & editing

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Alexander Schinagl

Roles Funding acquisition, Validation, Writing – review & editing

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Randolf J. Kerschbaumer

Roles Funding acquisition, Validation, Writing – review & editing

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Frederick W. K. Tam

Roles Conceptualization, Supervision, Writing – review & editing

Affiliation Department of Immunology and Inflammation, Centre for Inflammatory Disease, Hammersmith Hospital, Imperial College London (ICL), London, United Kingdom

Christine Landlinger

Contributed equally to this work with: Christine Landlinger, Michael Thiele

Roles Conceptualization, Supervision, Writing – review & editing

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Michael Thiele

Contributed equally to this work with: Christine Landlinger, Michael Thiele

Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

michael.thiele@oncoone.com

Affiliation OncoOne Research & Development GmbH, Vienna, Austria

Competing Interests

At the time of the study MF, JM, AAPT, AS, RJK, CL and MT were full-time employees of OncoOne R&D GmbH (Vienna, Austria), MT, AS and RK hold ownership interests including shares of OncoOne (OO) R&D GmbH and patents related to the work described here. LHC, MP and FWKT received a sponsorship from OO to conduct the in vivo experiments. FWKT is a medical consultant for OO.